ERBB2 and breast cancer: Similarly, Breslin et al. used the HER2-positive breast cancer cell line as a 3D MCA model (BT474, HCC1954 and EFM192A) and found that cells cultured by the 3D method showed more drug resistance to anticancer agents than cells cultured in 2D conditions [37].